Newsroom

Patient Navigation in Immuno-Oncology


(AJMC.org) BEING DIAGNOSED WITH CANCER is often the scariest news a patient will hear in his or her lifetime. In addition to the physical toll of the disease itself, there are numerous other factors associated ...

Cooling Down ICER? Five Questions to Consider


(ACCCBuzz) Jan 25, 2017 – Although the value-based reimbursement train has definitely left the station and is picking up speed, those in the oncology community continue to grapple with the thorny ...

Bristol-Myers Squibb Enters Collaboration to Leverage Foundation Medicine’s Molecular Information Platform to Identify Predictive Biomarkers Across Multiple Tumor Types and Immunotherapy Agents


(BMS) Mar 30, 2017 - Bristol-Myers Squibb Company and Foundation Medicine today announced a collaboration that leverages Foundation Medicine’s comprehensive genomic profiling and molecular information solutions to identify predictive biomarkers such as Tumor Mutational Burden (TMB) and Microsatellite Instability (MSI) in patients enroll...

Novartis Announces First CAR-T Cell Therapy BLA for Pediatric and Young Adult Patients with R/R B-Cell ALL Granted FDA Priority Review


(Novartis) Mar 29, 2017 - Novartis announced today that the US Food and Drug Administration (FDA) has accepted the company's Biologics License Application (BLA) filing and granted priority review for CTL019 (tisagenlecleucel-T), an investigational chimeric antigen receptor T cell (CAR-T) therapy, in relapsed and refractory (r/r) pediatric...

Penn Studies Find Promise for Innovations in Liquid Biopsies


(Penn Medicine) Mar 29, 2017 - A series of studies from the Perelman School of Medicine at the University of Pennsylvania demonstrate the promise of new diagnostic methods. Three of the studies focus on liquid biopsies, an innovation which uses blood tests instead of surgical procedures in hopes of detecting cancer. ...